{
    "2021-05-06": [
        [
            {
                "time": "",
                "original_text": "定增解禁第一天就放量大跌，外资和冯柳都在砸盘？ 解禁",
                "features": {
                    "keywords": [
                        "定增解禁",
                        "放量大跌",
                        "外资",
                        "冯柳",
                        "砸盘"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "热景生物轰出6个20cm！利益面前，规则算逑？达晨系基金违规清仓减持 金融监管处罚",
                "features": {
                    "keywords": [
                        "热景生物",
                        "20cm",
                        "违规清仓减持",
                        "金融监管",
                        "处罚"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药行业2020年年报及2021年一季报总结：Q1业绩复苏回暖 看好CXO、疫苗、创新器械和服务等高景气板块",
                "features": {
                    "keywords": [
                        "医药行业",
                        "年报",
                        "一季报",
                        "Q1业绩复苏",
                        "CXO",
                        "疫苗",
                        "创新器械",
                        "服务"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "海外策略｜海外“全中国组合”—2021年5月",
                "features": {
                    "keywords": [
                        "海外策略",
                        "全中国组合",
                        "2021年5月"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}